about
Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratificationAnti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel diseaseHigh levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous diseaseBiomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel diseaseNeutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseasesLaboratory markers in ulcerative colitis: Current insights and future advancesBiomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's diseaseBiomarkers in inflammatory bowel disease: current practices and recent advances.Circulating microRNA is a biomarker of pediatric Crohn disease.Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's diseaseSerologic antiglycan antibodies in inflammatory bowel disease.Serological antibodies in inflammatory bowel disease: a systematic review.Serological markers of inflammatory bowel disease.Functional analysis of agalactosyl IgG in inflammatory bowel disease patients.Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.Gastrointestinal-associated autoantibodies in different autoimmune diseases.Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis.Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.Circulating CD4(+)CXCR5(+) T Cells Exacerbate B Cell Antibody Production in Crohn's Disease Through IL-21 SecretionDiagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control studyLow Mannan-Binding Lectin Serum Levels Are Associated With Complicated Crohn's Disease and Reactivity to Oligomannan (ASCA)
P2860
Q22241487-0FEDCADC-2490-45FB-8307-E53457DA0259Q22242053-164A3B4F-8E48-4A82-9C47-1A75E439F5ABQ24633510-26996C0D-4262-412E-99F0-9830B051A0FCQ26740542-B4C34C1B-AC69-4FFA-A701-15CA2E57EE55Q26745775-2FD04FE3-3EE7-4A49-90C2-79551B903B91Q27027022-918DB43F-8295-4963-A5C5-74DEC655CDCDQ34413480-2935E16E-9432-4D89-BD2D-23221AF95D7CQ35058495-5DB85AC9-8E21-4680-876C-ACE0DA4391F6Q35840853-A87C1D81-69A9-4C41-BCDC-282340D863A1Q37254246-312E8E5C-EAB4-4D39-8103-9B9BD833C85FQ37284803-60B4F5B9-0390-413A-B2AE-003B9964D582Q37829904-FE2CF0AE-7143-48EC-9F54-683E15164A7BQ37954231-182F296C-B27C-4526-AF6C-CF5B7C60167EQ38086247-9289B316-9988-4292-93EF-698AA95CFC28Q38341038-C868360D-3ED4-4BFB-A88C-E93A372A912DQ40457215-4C69A7BF-BF77-47A8-8B05-E65DBACA04EEQ42004096-168B33B1-9A48-4FB2-AAF3-EFFBBFA1BF68Q42126789-3ED49516-4932-435D-B929-E3FE9BF85552Q47661706-904D5F26-FC5A-4ED8-B323-71B13C75528CQ51674064-AF057D03-05FF-4ACE-8723-9C845F99B43FQ56512201-0ECA2733-8A32-4ACF-B231-E0C286F46857Q58789070-2CA0C6C5-BE95-4943-926C-B3C8F06252A5Q58806614-B7D73E24-94AC-4683-84A3-E1EF20A9803D
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Serological markers in inflammatory bowel diseases.
@ast
Serological markers in inflammatory bowel diseases.
@en
type
label
Serological markers in inflammatory bowel diseases.
@ast
Serological markers in inflammatory bowel diseases.
@en
prefLabel
Serological markers in inflammatory bowel diseases.
@ast
Serological markers in inflammatory bowel diseases.
@en
P2093
P356
P1476
Serological markers in inflammatory bowel diseases
@en
P2093
Dominique Reumaux
Jean-Frédéric Colombel
Patrick Duthilleul
P356
10.1053/BEGA.2002.0347
P577
2003-02-01T00:00:00Z